China-based Yuwell Medical recently held its 2025 Global Core Partner Conference in Dubai, and announced a strategic investment and partnership with Inogen, a leading US-based company in respiratory health, highlighting its joint commitment to advancing medical device solutions and deeper collaboration.
Speaking at the Yuwell Medical 2025 Global Core Partner Conference, Alex WU, Chairman of Yuwell Medical, stated that as a leading enterprise in China's home medical device industry, Yuwell will rely on internal growth and external mergers and acquisitions to promote internationalisation. The company has updated its new vision for the next five years: to become top three companies in the global home medical health market in the mid-to-long term. Among them, respiratory treatment solutions, diabetes care, and emergency service solutions are the three key strategic sectors.
The company will further strengthen its globalisation strategy from three aspects: organisational structure expansion, recruitment of outstanding overseas talents product R&D innovation, and supply chain integration innovation.
During the conference, Yuwell Medical and the American company Inogen formalised their collaboration by signing a strategic investment and cooperation memorandum, further deepening their partnership in the respiratory segment.
As one of the world's largest manufacturers of oxygen concentrators, Yuwell Medical is widely recognized for its strong R&D capabilities and advanced manufacturing capabilities.
Inogen brings extensive experience in portable oxygen concentrator technology. Yuwell, through its whole-owned subsidiary Yuwell (Hong Kong) Holdings Limited, has agreed to invest approximately $27.2 million in Inogen, representing 9.9% of the outstanding shares of Inogen's common stock upon closing of this investment.
The two companies seek to upgrade devices technology through deepened collaboration. By combining their expertise and brand in their respective industry segments and geographies, Yuwell and Inogen agree to carry out in-depth strategic cooperation based on business synergy in four aspects: international distribution business, trademark licensing and distribution business, joint research and development, and supply chain optimisation.
